Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Vascul Pharmacol ; 44(3): 149-55, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16423564

ABSTRACT

We previously showed that the major Zn-binding protein, metallothionein (MT) is a critical target for nitric oxide (NO) with resultant increases in labile Zn. We now show that NO donors also affected the activity of the metal responsive transcription factor MTF-1 that translocates from the cytosol to the nucleus in response to physiologically relevant increases in intracellular Zn and transactivates MT gene expression. Exposing mouse lung endothelial cells (MLEC) to ZnCl(2) or the NO donor, S-Nitroso-N-acetylpenicillamine (SNAP, 200 microM), caused nuclear translocation of a reporter molecule consisting of enhanced green fluorescent protein (EGFP) fused to MTF-1 (pEGFP-MTF-1). In separate experiments, NO donors induced increases in MT protein levels (Western blot). In contrast, NO did not cause nuclear translocation of EGFP-MTF-1 in MLEC from MT knockouts, demonstrating a central role for MT in mediating this response. These data suggest that S-nitrosation of Zn-thiolate clusters in MT and subsequent alterations in Zn homeostasis are participants in intracellular NO signaling pathways affecting gene expression.


Subject(s)
Cell Nucleus/metabolism , DNA-Binding Proteins/genetics , Endothelial Cells/metabolism , Metallothionein/metabolism , Recombinant Fusion Proteins/metabolism , Transcription Factors/genetics , Active Transport, Cell Nucleus , Animals , Cell Nucleus/drug effects , Cells, Cultured , Chlorides/pharmacology , Endothelial Cells/drug effects , Green Fluorescent Proteins/genetics , Lung/blood supply , Metallothionein/genetics , Mice , Mice, Knockout , Nitric Oxide/metabolism , Nitric Oxide Donors/pharmacology , S-Nitroso-N-Acetylpenicillamine/pharmacology , Sheep , Transfection , Zinc/metabolism , Zinc Compounds/pharmacology , Transcription Factor MTF-1
2.
Am J Physiol Lung Cell Mol Physiol ; 282(2): L185-92, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11792622

ABSTRACT

We hypothesized that metallothionein (MT), a cysteine-rich protein with a strong affinity for Zn(2+), plays a role in nitric oxide (NO) signaling events via sequestration or release of Zn(2+) by the unique thiolate clusters of the protein. Exposing mouse lung fibroblasts (MLF) to the NO donor S-nitrosocysteine resulted in 20-30% increases in fluorescence of the Zn(2+)-specific fluorophore Zinquin that were rapidly reversed by the Zn(2+) chelator N,N,N',N'-tetrakis-(2-pyridylmethyl)ethylenediamine. The absence of a NO-mediated increase in labile Zn(2+) in MLF from MT knockouts and its restoration after MT complementation by adenoviral gene transfer inferred a critical role for MT in the regulation of Zn(2+) homeostasis by NO. Additional data obtained in sheep pulmonary artery endothelial cells suggested a role for the apo form of MT, thionein (T), as a Zn(2+)-binding protein in intact cells, as overexpression of MT caused inhibition of NO-induced changes in labile Zn(2+) that were reversed by Zn(2+) supplementation. Furthermore, fluorescence-resonance energy-transfer data showed that overexpression of green fluorescent protein-modified MT prevented NO-induced conformational changes, which are indicative of Zn(2+) release from thiolate clusters. This effect was restored by Zn(2+) supplementation. Collectively, these data show that MT mediates NO-induced changes in intracellular Zn(2+) and suggest that the ratio of MT to T can regulate Zn(2+) homeostasis in response to nitrosative stress.


Subject(s)
Cysteine/analogs & derivatives , Homeostasis/physiology , Lung/metabolism , Metallothionein/metabolism , Nitric Oxide/metabolism , Zinc/metabolism , Animals , Cells, Cultured , Chelating Agents/pharmacology , Cysteine/pharmacology , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Ergothioneine/metabolism , Ethylenediamines/pharmacology , Female , Fibroblasts/cytology , Fibroblasts/metabolism , Fluorescent Dyes , Gene Expression/physiology , Lung/cytology , Male , Metallothionein/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Nitric Oxide Donors/pharmacology , Pulmonary Artery/cytology , Quinolones , S-Nitrosothiols/pharmacology , Sheep , Spectrometry, Fluorescence , Tosyl Compounds , Zinc/pharmacology
3.
Am J Physiol Lung Cell Mol Physiol ; 281(1): L243-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11404267

ABSTRACT

Although zinc is a well-known inhibitor of apoptosis, it may contribute to oxidative stress-induced necrosis. We noted that N,N,N',N'- tetrakis(2-pyridylmethyl)ethylenediamine (TPEN; >10 microM), a zinc chelator, quenched fluorescence of the zinc-specific fluorophore Zinquin and resulted in an increase in spontaneous apoptosis in cultured sheep pulmonary artery endothelial cells (SPAECs). Addition of exogenous zinc (in the presence of pyrithione, a zinc ionophore) to the medium of SPAECs caused an increase in Zinquin fluorescence and was associated with a concentration-dependent increase in necrotic cell death. Exposure of SPAECs to TPEN (10 microM) resulted in enhanced apoptosis after lipopolysaccharide or complete inhibition of t-butyl hydroperoxide (tBH)-induced necrosis. We further investigated the role of two zinc-dependent enzymes, poly(ADP-ribose) polymerase (PARP) and protein kinase (PK) C, in tBH toxicity. tBH toxicity was only affected by the PARP inhibitors 4-amino-1,8-naphthalimide or 3-aminobenzamide over a narrow range, whereas the PKC inhibitors bisindolylmaleimide and staurosporine significantly reduced tBH toxicity. tBH caused translocation of PKC to the plasma membrane of SPAECs that was partially inhibited by TPEN. Thus pulmonary endothelial cell zinc inhibits spontaneous and lipopolysaccharide-dependent apoptosis but contributes to tBH-induced necrosis, in part, via a PKC-dependent pathway.


Subject(s)
Endothelium, Vascular/physiology , Oxidative Stress , Pulmonary Circulation/physiology , Zinc/physiology , Animals , Apoptosis/drug effects , Cells, Cultured , Endothelium, Vascular/drug effects , Endothelium, Vascular/pathology , Lipopolysaccharides/pharmacology , Necrosis , Poly(ADP-ribose) Polymerases/physiology , Protein Kinase C/physiology , Pulmonary Circulation/drug effects , Sheep , Zinc/pharmacology , tert-Butylhydroperoxide/poisoning
4.
Shock ; 15(1): 73-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11198361

ABSTRACT

Induction of the heat shock response protects animals from either endotoxemia or peritonitis. In endotoxemia, heat shock protein (HSP) induction is associated with reversal of vascular hyporeactivity and inhibition of iNOS expression. Recent studies suggest differences in the inflammatory mechanisms during endotoxemia and peritonitis animal models and their response to therapeutic interventions. We therefore studied the effect of the HSP inducer sodium arsenite (SA) on vascular reactivity and iNOS expression in rats undergoing cecal ligation and puncture (CLP). CLP resulted in suppression of the pressor effect of norepinephrine (NE) in vivo (measured by changes in blood pressure in response to NE boluses) and ex vivo (changes in contraction force in isolated mesenteric arteries in response to NE concentrations), and in the expression of iNOS protein. Pretreatment of the rats with SA resulted in reversal of CLP-induced vascular hyporeactivity in vivo and ex vivo, and inhibition of iNOS expression after 22 h. SA pretreatment improved 7-day survival after CLP from 18.2% to 70% (P < 0.005). Glucocorticoid receptor inhibition did not affect the effect of HSP induction on iNOS expression. The similarity of the effect of HSP on vascular reactivity and iNOS expression in two distinct sepsis models suggests that this effect may be clinically important and that a causative relationship between HSP induction, iNOS inhibition, and reversal of vascular reactivity is likely.


Subject(s)
Arsenites/pharmacology , Nitric Oxide Synthase/metabolism , Sepsis/metabolism , Sodium Compounds/pharmacology , Vasoconstriction/drug effects , Animals , Blood Vessels/drug effects , Blood Vessels/physiology , Cecum/surgery , Enzyme Inhibitors/pharmacology , Heat-Shock Proteins/drug effects , Heat-Shock Proteins/metabolism , Ligation , Male , Mesentery , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase Type II , Norepinephrine/pharmacology , Punctures , Rats , Rats, Wistar , Sepsis/mortality , Sepsis/physiopathology , Survival Rate , Vasoconstrictor Agents/pharmacology
5.
Am J Respir Crit Care Med ; 162(1): 288-94, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10903256

ABSTRACT

Actin released from damaged cells after a variety of tissue injuries appears to be involved in multiple organ dysfunction syndrome. Under experimental conditions, when the quantity of actin present in plasma is made to exceed the protective capacity of the actin-scavenging mechanism, microembolism and pulmonary vascular angiopathy have been noted in rats. It remains to be determined whether this injury is a result of a direct toxic effect or occurs indirectly via platelet activation or fibrin interactions. We examined the effect of sera from patients with adult respiratory distress syndrome (ARDS), as well as G-actin added to normal serum, on the viability, morphology, and function of cultured sheep pulmonary artery endothelial cells (SPAEC). Both patient sera and normal sera to which actin was added were toxic in the cell culture model; this toxicity could be abrogated, at least partially, by preincubation with gelsolin, which is known to complex with actin. A significant portion of the toxicity of sera from patients with ARDS was sensitive to heat (56 degrees C), suggesting an important role of complement. Sera from patients with ARDS were shown to contain filaments of F-actin by immunoblot and rhodamine phalloidin staining after ultracentrifugation. Thus, saturation of the actin-scavenging system by addition of exogenous G-actin to plasma produces direct pulmonary endothelial cell injury. Furthermore, plasma from patients with ARDS secondary to bacterial pneumonia is toxic to SPAEC, and a small but significant contributory role of actin is apparent in these studies.


Subject(s)
Actins/blood , Actins/toxicity , Endothelium, Vascular/cytology , Pulmonary Artery/cytology , Respiratory Distress Syndrome/blood , Animals , Cells, Cultured , Humans , Sheep
6.
J Nutr ; 130(5S Suppl): 1467S-70S, 2000 05.
Article in English | MEDLINE | ID: mdl-10801961

ABSTRACT

Recent in vitro studies suggest that the oxidoreductive capacity of metal thiolate clusters in metallothionein (MT) contributes to intracellular zinc homeostasis. We used fluorescence-based techniques to address this hypothesis in intact endothelial cells, focusing on the contributory role of the important redox signaling molecule, nitric oxide. Microspectrofluorometry with Zinquin revealed that the exposure of cultured sheep pulmonary artery endothelial cells to S-nitrosocysteine resulted in the release of N, N,N',N'-tetrakis(2. pyridylmethyl)ethylendiamine (TPEN) chelatable zinc. Cultured sheep pulmonary artery endothelial cells were transfected with a plasmid expression vector suitable for fluorescence resonance energy transfer containing the cDNA of MT sandwiched between two mutant green fluorescent proteins. The exposure of cultured sheep pulmonary artery endothelial cells transfected with this chimera to nitric oxide donors or to agents that increased cytoplasmic Ca(2+) via endogenously generated nitric oxide decreased the efficiency of fluorescence resonance energy transfer in a manner consistent with the release of metal (Zn) from MT. A physiological role for this interaction in intact tissue was supported by the lack of myogenic reflex in resistance arteries of MT knockout mice unless endogenous nitric oxide synthesis was blocked. These data suggest an important role for metal thiolate clusters of MT in nitric oxide signaling in the vascular wall.


Subject(s)
Antioxidants/pharmacology , Endothelium, Vascular/physiology , Homeostasis/physiology , Metallothionein/physiology , Nitric Oxide/pharmacology , S-Nitrosothiols , Zinc/physiology , Animals , Cells, Cultured , Chelating Agents/metabolism , Chelating Agents/pharmacology , Cysteine/analogs & derivatives , Cysteine/pharmacology , Drug Interactions , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Ethylenediamines/metabolism , Ethylenediamines/pharmacology , Fluorescent Dyes/metabolism , Fluorescent Dyes/pharmacology , Homeostasis/drug effects , Mice , Mice, Knockout , Nitroso Compounds/pharmacology , Oxidation-Reduction/drug effects , Pulmonary Artery , Quinolones/metabolism , Quinolones/pharmacology , Sheep , Tosyl Compounds/metabolism , Tosyl Compounds/pharmacology , Zinc/pharmacology
7.
Proc Natl Acad Sci U S A ; 97(1): 477-82, 2000 Jan 04.
Article in English | MEDLINE | ID: mdl-10618443

ABSTRACT

Although the function of metallothionein (MT), a 6- to 7-kDa cysteine-rich metal binding protein, remains unclear, it has been suggested from in vitro studies that MT is an important component of intracellular redox signaling, including being a target for nitric oxide (NO). To directly study the interaction between MT and NO in live cells, we generated a fusion protein consisting of MT sandwiched between two mutant green fluorescent proteins (GFPs). In vitro studies with this chimera (FRET-MT) demonstrate that fluorescent resonance energy transfer (FRET) can be used to follow conformational changes indicative of metal release from MT. Imaging experiments with live endothelial cells show that agents that increase cytoplasmic Ca(2+) act via endogenously generated NO to rapidly and persistently release metal from MT. A role for this interaction in intact tissue is supported by the finding that the myogenic reflex of mesenteric arteries is absent in MT knockout mice (MT(-/-)) unless endogenous NO synthesis is blocked. These results are the first application of intramolecular green fluorescent protein (GFP)-based FRET in a native protein and demonstrate the utility of FRET-MT as an intracellular surrogate indicator of NO production. In addition, an important role of metal thiolate clusters of MT in NO signaling in vascular tissue is revealed.


Subject(s)
Luminescent Proteins/genetics , Metallothionein/metabolism , Nitric Oxide/metabolism , Animals , Arginine/pharmacology , Calcium/metabolism , Endothelium, Vascular/metabolism , Glutathione/analogs & derivatives , Glutathione/metabolism , Green Fluorescent Proteins , Image Processing, Computer-Assisted , Kinetics , Male , Mesenteric Arteries , Metallothionein/genetics , Mice , Mice, Inbred Strains , Mice, Knockout , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitroso Compounds/metabolism , Protein Conformation , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , S-Nitrosoglutathione , Signal Transduction , Spectrometry, Fluorescence
8.
Am J Physiol ; 273(4): L856-65, 1997 10.
Article in English | MEDLINE | ID: mdl-9357862

ABSTRACT

Metallothionein (MT) is a low-molecular-weight cysteine-rich protein with extensive metal binding capacity and potential nonenzymatic antioxidant activity. Despite the sensitivity of vascular endothelium to either heavy metal toxicity or oxidative stress, little is known regarding the role of MT in endothelial cells. Accordingly, we determined the sensitivity of cultured sheep pulmonary artery endothelial cells (SPAEC) that overexpressed MT to tert-butyl hydroperoxide (t-BOOH), hyperoxia, or 2,2'-azobis(2,4-dimethylvaleronitrile) (AMVN; peroxyl radical generator). Nontoxic doses of 10 microM Cd increased MT levels from 0.21 +/- 0.03 to 2.07 +/- 0.24 microg/mg and resulted in resistance to t-BOOH and hyperoxia as determined by reduction of Alamar blue or [3H]serotonin transport, respectively. SPAEC stably transfected with plasmids containing either mouse or human cDNA for MT were resistant to both t-BOOH and hyperoxia. In addition, we examined transition metal-independent, noncytotoxic AMVN-induced lipid peroxidation after metabolic incorporation of the oxidant-sensitive fluorescent fatty acid cis-parinaric acid into phospholipids and high-performance liquid chromatography separation. SPAEC that overexpressed MT after gene transfer completely inhibited peroxyl oxidation of phosphatidylserine, phosphatidylcholine, and sphingomyelin (but not phosphatidylethanolamine) noted in wild-type SPAEC. These data show for the first time that MT can 1) protect pulmonary artery endothelium against a diverse array of prooxidant stimuli and 2) directly intercept peroxyl radicals in a metal-independent fashion, thereby preventing lipid peroxidation in intact cells.


Subject(s)
Endothelium, Vascular/metabolism , Metallothionein/biosynthesis , Animals , Azo Compounds/pharmacology , Cell Membrane/metabolism , Cells, Cultured , Chromatography, High Pressure Liquid , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Humans , Lipid Peroxidation , Membrane Lipids/metabolism , Mice , Nitriles/pharmacology , Oxidation-Reduction , Oxygen/pharmacology , Peroxides/pharmacology , Phospholipids/analysis , Phospholipids/metabolism , Promoter Regions, Genetic , Pulmonary Artery , Reactive Oxygen Species , Recombinant Proteins/biosynthesis , Sheep , Transfection , tert-Butylhydroperoxide
9.
Am J Physiol ; 271(6 Pt 2): H2529-35, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8997314

ABSTRACT

Endotoxin (lipopolysaccharide, LPS)-induced hypotension is, in part, mediated via induction of nitric oxide synthase (iNOS), release of nitric oxide, and suppression of vascular reactivity (vasoplegia). Induction of heat shock proteins (HSP) or inhibition of iNOS expression improves survival in LPS-challenged rodents. We studied the effect of induction of HSP on LPS-mediated iNOS expression and on LPS-induced vasoplegia and hypotension. Rats were treated with the HSP inducer sodium arsenite (6 mg/kg iv) or saline control. Seventeen hours later, rats were challenged intravenously with 10 mg/kg of Escherichia coli LPS O127:B8 or saline control. Arsenite pretreatment resulted in expression of HSP 70 mRNA and of HSP 70 and heme oxygenase-1 proteins, inhibition of LPS-mediated iNOS mRNA induction, reversal of the LPS-induced hyporesponsiveness to norepinephrine ex vivo in isolated mesenteric arteries, and attenuation of LPS-induced hypotension in vivo. Our data suggest that induction of HSP expression protects rats from LPS by blocking LPS-induced iNOS expression, leading to inhibition of the overproduction of nitric oxide and thereby reversing LPS-induced vasoplegia and LPS-induced hypotension.


Subject(s)
Endotoxins/pharmacology , HSP70 Heat-Shock Proteins/metabolism , Hypotension/physiopathology , Nitric Oxide Synthase/genetics , RNA, Messenger/metabolism , Animals , Arsenites/pharmacology , Dogs , Enzyme Induction , Escherichia coli , Heme Oxygenase (Decyclizing)/metabolism , Hemodynamics/drug effects , Lipopolysaccharides/pharmacology , Male , Norepinephrine/pharmacology , Rats , Rats, Wistar , Sodium Compounds/pharmacology , Splanchnic Circulation/drug effects , Vasoconstriction
10.
Am J Physiol ; 271(1 Pt 1): L166-71, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8760147

ABSTRACT

Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L166-L171, 1996.-Interleukin-1 beta (IL-1 beta) is the critical cytokine affecting peripheral vascular expression of inducible nitric oxide synthase (iNOS). Accordingly, we sought to determine a role for IL-1 beta in stimulating iNOS transcription in cultured rat pulmonary artery smooth muscle cells (RPASMC). Treatment of RPASMC with IL-1 beta caused a concentration-dependent increase in iNOS gene expression by Northern and Western blotting. To demonstrate IL-1 beta-mediated transcriptional activation, we used transient liposome-mediated transfection of RPASMC with promoter-luciferase constructs containing deletional mutations of the murine macrophage iNOS 5' flanking promoter region. IL-1 beta increased promoter activity approximately two- to threefold over baseline in fragments ranging from -1592 (full-length) to -242 bp. Activity was lost, however, when the promoter fragment was shorter than -242 bp. IL-1 beta-mediated increases in steady-state iNOS mRNA were sensitive to pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-kappa B activation. Nuclear proteins from IL-1 beta-stimulated cells demonstrated PDTC-sensitive binding to an oligonucleotide containing the sequence for the NF-kappa B binding element present in the region between -242 and -42 bp. These data document that IL-1 beta, by itself, increases iNOS expression in RPASMC by transcriptional activation, mediated in part by NF-kappa B.


Subject(s)
Interleukin-1/pharmacology , Muscle, Smooth, Vascular/enzymology , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Pulmonary Artery/enzymology , Transcription, Genetic/drug effects , Animals , Base Sequence , Cells, Cultured , Electrophoresis , Enzyme Induction/drug effects , Gene Expression/drug effects , Male , Molecular Sequence Data , Muscle, Smooth, Vascular/cytology , NF-kappa B/antagonists & inhibitors , Oligonucleotide Probes , Pulmonary Artery/cytology , Pyrrolidines/pharmacology , Rats , Rats, Sprague-Dawley , Thiocarbamates/pharmacology
11.
Am J Physiol ; 269(6 Pt 1): L843-8, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8572246

ABSTRACT

The heat shock response is a highly conserved stress response known to alter patterns of gene expression in many cell types. We hypothesized that interleukin-1 beta (IL-1 beta)-mediated inducible nitric oxide synthase (iNOS) gene expression would be inhibited after induction of the heat shock response in cultured rat pulmonary artery smooth muscle cells (RPASMC). Exposure of RPASMC to sodium arsenite or heat led to expression of heat shock protein-70 (HSP-70) in a time- and concentration-dependent manner. Prior induction of the heat shock response inhibited IL-1 beta-mediated iNOS gene expression in a time- and dose-dependent manner. The inhibitory effects were not due to cytotoxicity, since cell viability was not affected by either sodium arsenite, heat, IL-1 beta, or their combination. Transcriptional analysis via transient transfection of the murine macrophage iNOS promoter [-1592 and -367 base pairs (bp)], upstream from the reporter gene luciferase, revealed that the heat shock response did not affect IL-1 beta-mediated promoter activation, as measured by luciferase activity. We conclude that induction of the heat shock response inhibits IL-1 beta-mediated iNOS gene expression in cultured RPASMC.


Subject(s)
Hot Temperature , Muscle, Smooth, Vascular/enzymology , Nitric Oxide Synthase/antagonists & inhibitors , Pulmonary Artery/enzymology , Shock/enzymology , Animals , Arsenites/pharmacology , Cells, Cultured , Enzyme Induction , Gene Expression/drug effects , Heat-Shock Proteins/genetics , Interleukin-1/physiology , Male , Muscle, Smooth, Vascular/pathology , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Promoter Regions, Genetic/drug effects , Pulmonary Artery/pathology , Rats , Rats, Sprague-Dawley , Shock/pathology , Sodium Compounds/pharmacology
12.
Am J Physiol ; 268(5 Pt 1): L862-7, 1995 May.
Article in English | MEDLINE | ID: mdl-7539224

ABSTRACT

We have previously reported that a mixture of lipopolysaccharide and cytokines stimulates cultured rat pulmonary artery smooth muscle cells (RPASM) to express elevated levels of mRNA for inducible nitric oxide synthase (iNOS), and to produce large amounts of nitric oxide (NO). The current study tests the hypothesis that transforming growth factor-beta (TGF-beta) modulates this process. Accordingly, RPASM were treated with a mixture of LPS (10 micrograms/ml) and the cytokines interleukin-1 beta (5 U/ml), tumor necrosis factor-alpha (500 U/ml), and interferon-gamma (100 U/ml). In the absence of TGF-beta 1, NO production (indicated by colorimetric assay of cumulative nitrite levels at 24 h) was greatly increased, as previously observed. Under identical conditions, TGF-beta 1 caused a concentration-dependent decrease in NO production. The addition of neither excess L-arginine nor sepiapterin reversed the inhibition, indicating that the effect of TGF-beta 1 was not due to limitation of enzyme substrate or cofactor tetrahydrobiopterin, respectively. Northern and Western analyses showed that TGF-beta 1 reduced levels of iNOS mRNA and protein to baseline at all time points examined up to 24 h. Complete suppression of iNOS protein expression was evident even when TGF-beta 1 was added at postinduction time points. One mechanism of action of TGF-beta 1 was demonstrated in experiments in which degradation of iNOS protein was greatly increased by the addition of TGF-beta 1. These results demonstrate that TGF-beta 1 regulates production of NO in RPASM by inhibiting iNOS expression in part by increasing degradation of existing iNOS protein.


Subject(s)
Amino Acid Oxidoreductases/antagonists & inhibitors , Muscle, Smooth, Vascular/metabolism , Nitric Oxide/metabolism , Pulmonary Artery/metabolism , Transforming Growth Factor beta/pharmacology , Amino Acid Oxidoreductases/chemistry , Amino Acid Oxidoreductases/genetics , Animals , Cytokines/pharmacology , Drug Stability , Enzyme Induction , Lipopolysaccharides/pharmacology , Male , Muscle, Smooth, Vascular/cytology , Nitric Oxide Synthase , Nitrites/metabolism , Pulmonary Artery/cytology , RNA, Messenger/antagonists & inhibitors , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...